Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-103-8 | CAS number: 68187-51-9 This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77496.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
Seven different types of iron oxides were examined for carcinogenic properties after intratracheal instillation and intraperitoneal injection tests in rats, which represent particularly sensitive methods for local carcinogenic effects of particles/fibres. The total doses lay in the range of maximum tolerance.
The JECFA (1980) evaluation reported that iron oxide (unspecified compound) in the diet at levels up to 10 g/kg did not result in adverse effects in dogs and cats (no further details reported). These unpublished studies were more fully described in the JECFA evaluation report on iron (1983). In an unpublished study from Carnation Co. (1967), ten dogs were fed on diets containing iron oxide colourant from 1 to 9 years at about 570 mg/lb (equivalent to 1.25 g/kg diet, 0.312 mg/kg bw/day19). Daily consumption was estimated at 428 mg/dog. Two Labradors, fed for 1 year, had loose faeces; otherwise, no adverse effects were observed. In a study from Ralston Purina Cat Care Center (1968), no adverse effects were reported in cats maintained on diets containing 1 900 mg/kg diet (475 mg/kg bw/day) of iron from iron oxide (equivalent to 0.27 % iron oxide) for periods of 2–9 years (EFSA, 2015).
The carcinogenicity of ferric chloride (FeCl3), a compound that is used as a food additive, a haemostatic or treatment for hypochromic anaemia, was examined in F344 rats of both sexes. It was dissolved in distilled water at levels of 0, 0.25 or 0.5%, and groups of 50 male and 50 female rats were given one of these solutions ad lib. as their drinking water for up to 2 yr. The mean body weights of the treated rats were lower than control group values for both males and females. A variety of tumours developed in all groups, including the control group, but all these neoplasms were histologically similar to those known to occur spontaneously in this strain of rats, and no statistically significant increase in the incidence of any tumour was found in the treated groups of either sex. Thus, it is concluded that under the conditions of this experiment, ferric chloride exerts no carcinogenic potential in F344 rats (Sato et al, 1992).
Overall, given that the soluble iron trichloride has been shown to be negative in a carcinogenicity assay, since red iron oxides in contrast are of negligible bioavailability, the carcinogenicity hazard for red iron oxide is deemed to be similarly negligible.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the available data (see discussion) a classification is not justified.
Additional information
In the key studies seven different types of iron oxides were examined for carcinogenic properties after intratracheal instillation and intraperitoneal injection tests in rats, which represent particularly sensitive methods for local carcinogenic effects of particles/fibres. The total doses lay in the range of maximum tolerance. No carcinogenic effect was observed. Overall, based on a weight-of-evidence consideration there is no evidence of a carcinogenic potential of iron oxides from animal data. From epidemiological studies there is no evidence for carcinogenicity after exposure to zinc or its compounds through relevant routes of exposure. No valid studies are available for Mn3O4. There are no epidemiological data showing that excess manganese will cause cancer in human beings. Based on the physico-chemical properties, the negative genotoxicity data as well as the lack of specific long term local effects in the most valid studies with intraperitoneal (i.p.) administration there is no evidence of any specific toxicity. This is confirmed by the result of the subchronic inhalation study with Fe3O4 that revealed findings consistent with a 'poorly soluble particle' and no specific toxicity. No analytical or toxicological evidence existed that free, biosoluble iron was liberated from the inhaled particle dust to any appreciable extent. Also no evidence of extrapulmonary toxicity existed. Haematology, clinical pathology and urinalysis were unobtrusive and no specific clinical signs were observed during the study.
A human study is available with the objective to study the possible association between iron oxide exposures and lung cancer risk among workers employed in a French carbon steel-producing factory. A historical cohort was set up of all workers ever employed for at least one year between 1959 and 1997. The cohort was followed up for mortality from January 1968 to December 1998. Causes of death were ascertained from death certificates. Job histories in the factory and smoking habits were available. Occupational exposures were assessed by a factory-specific job-exposure matrix (JEM) developed by a panel of 8 experts and validated with atmospheric measurements. Standardized Mortality Ratios (SMRs) were computed using local death rates (external references). Poisson regressions were used to estimate the Relative Risks (RRs) for occupational exposures (internal references), adjusted on potential confounding factors (Bourgkard et al., 2008).
The cohort comprised 16,742 males and 959 females. Among males, the observed mortality was lower than expected for lung cancer when compared to the local population (233 deaths, SMR 0.89, 95%CI 0.78-1.01) and higher than expected when compared to the French population (SMR 1.30, 95%CI 1.15-1.48). No lung cancer excess was observed for exposure to iron oxides (RR 0.80, 95%CI 0.55-1.17) and no dose-response relationship was found with intensity, duration of exposure, and cumulative index. A significant bladder cancer excess was observed among workers exposed to oil mist, increasing significantly with intensity, duration of exposure, and cumulative index. The authors concluded: “This study did not detect any relationship between exposure to iron oxides and lung cancer mortality” (Bourgkard et al., 2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.